Powder Delivery TRIZ Cases

Polymeric nanoparticles conjugated with EGFR ligands deliver therapeutic agents to cartilage tissue via electrostatic interactions.

Lipid lubrication during roll milling achieves uniform nanoparticle size, while supercritical fluid extraction removes the mediator to prevent coagulation.

Discoidal lipid carriers encapsulate peptide nucleic acids to boost cellular uptake while reducing cytotoxicity and off-target effects.

Kaolin and probiotic powder reduces heat loss and pathogenic infections in newborn piglets.

Continuous polymetaphosphate lavage dissolves persistent CPPD and HAP crystals, resolving inflammation caused by static treatment limitations.

Cationic lipopeptides self-assemble into nanoparticles that reduce toxicity and improve biodistribution.

Biocompatible radiopaque gel fills surgical cavities to provide continuous X-ray visualization of target tissue boundaries.

PEGylated peptide amphiphiles form stable nanofibers that extend circulation time and enhance bioactivity of growth factor proteins.

Microneedles transport poorly soluble nanoparticles through intact skin, overcoming solubility limitations without medical assistance.

Hemiaminal ester prodrugs extend drug half-life and improve bioavailability for non-nucleoside reverse transcriptase inhibitors.

Polyanhydride nanoparticles deliver influenza antigens to lung tissue, generating robust local memory T cells and systemic antibodies.

Sucrose and methionine excipients stabilize recombinant acid sphingomyelinase, preventing aggregation during lyophilization.

Sucrose and poloxamer maintain enzymatic activity and receptor affinity in lyophilized fusion proteins despite complex excipient ratios.

Injectable hydroxy carbonate radioisotopes concentrate radiation at tumor sites, sparing surrounding healthy tissue from damage.

Lyophilization transforms unpalatable liquid camel urine into stable powder, enabling standardized dosing and eliminating contamination risks.

Cyclodextrin encapsulates araliadiol in a powdery preparation, preventing rapid deterioration and ensuring stable storage for pharmaceutical applications.

Heating gelatin at 100 to 121 degrees Celsius for 110 to 150 minutes prevents gelling during manufacturing while maintaining high radiochemical purity.

Composite liposomal structures encapsulate hydrophobic nutraceuticals within sealed water molecules, resolving solubility and colloidal stability trade-offs.

Novel ionizable lipids form lipid nanoparticles to protect nucleic acids from nuclease digestion while enhancing therapeutic index.

Repurposing Azelastine as an antiviral agent reduces viral load and protects against emerging SARS-CoV-2 variants without requiring new drug development.

Coordination assembly simplifies production of spherical metal-nucleic acid nanoparticles, resolving complexity issues in DNA nanostructure manufacturing.

Heat-inactivated Methanobrevibacter archaea cells preserve immune-modulating signals while eliminating methane production from live cultures.

Targeted nanoparticles overcome CT and MRI limitations by binding CCK-B receptors on precancerous lesions for early detection.

Removing serum albumin and polyethylene glycol prevents pharmaceutical contamination while sucrose and trehalose preserve viral stability.

Supercritical fluid processing deposits fine limus macrolide crystals onto excipients, resolving low bioavailability caused by insolubility in biological media.

Coating non-tobacco plant material with nicotine-in-glycerol solution delivers controlled nicotine content without undesirable tobacco organoleptic properties.

Amyloid beta short peptide modified liposomes adsorb plasma apolipoproteins to mediate drug transport across the blood-brain barrier.

Phenolic inhibitors suppress room-temperature polymerization of reactive maleimide groups, preventing gel formation and extending shelf life.

A hydrogel particle with a distinct core and matrix structure encapsulates magnetic material for cellular uptake.

Trehalose stabilizers and pH buffers maintain anti-PD-1 antibody integrity by preventing aggregation and deamidation during storage.

Nanoplatform assembly detects protease activity via spectral changes to differentiate cancer cells from healthy tissue.

Segmented lead nanoparticles in alginate gels resolve capillary clogging risks while delivering high radiopacity for safe vascular imaging.

A hybrid nanocurcumin formulation encapsulates curcumin within a lipid-polymer core to prevent QT prolongation while achieving sustained release.

Exogenous S-beta-hydroxybutyrate administration mediates the transition into ketosis, reducing hypoglycemia symptoms while sustaining elevated ketone levels.

Pegylated immunonanosomes deliver Bryoid and HDAC inhibitors to activate latent HIV reservoirs while reducing systemic toxicity.

Inhaled silver nanoparticles penetrate thick mucus layers to reach underlying respiratory tissue and bacteria within biofilms.

Tumor environment-sensitive cleavable polyethylene glycol conjugates to antibodies, enabling selective release in acidic microenvironments.

Nitrogen doped graphene oxide combined with manganese oxide nanoparticles creates a stable bimodal agent.

Electrospun matrices combine collagen and PLGA to provide mechanical strength while reducing adverse immune responses in tissue engineering.

Optimized TACI-Fc fusion protein reduces cytotoxicity while blocking BLyS signaling to treat systemic lupus erythematosus.

Self-assembling fusion peptides form protective monolayers around nucleic acids to enable safe intracellular transport.

Anti-nucleolin agent-conjugated nanoparticles target cancer cells to enhance radiation sensitivity and imaging contrast.

A lipid-based nanoparticle delivery system encapsulates nucleic acids encoding coronavirus spike proteins to induce strong immune responses.

Mannitol mediates romidepsin delivery to resolve formulation complexity while improving drug stability and bioavailability.

One-pot hydrothermal synthesis encapsulates porphyrin in carbon quantum dots, resolving preparation complexity while enabling targeted cancer treatment.

Inert atmosphere processing and lyophilized storage prevent oxidation and hydrolysis, maintaining therapeutic efficacy of rusalatide acetate compositions.

Oral bacterial compositions increase intestinal butyrate to mitigate graft-versus-host disease side effects from glucocorticoids.

Herbal extract composition acts as a selective estrogen receptor beta agonist to reduce hot flashes without activating estrogen receptor alpha.

Segmented hybrid nanocrystals maintain solid drug cores while surface ligands enable targeted delivery, avoiding solubility limits and reducing side effects.